Nektar Therapeutics (NKTR)

65.46 -0.10 (-0.15%) USD  |  NASDAQ  |  May 27, 16:00
66.55 +1.09 (+1.67%) After-Hours: 18:40
More

Nektar Therapeutics Average Diluted Shares Outstanding (Quarterly)

Average Diluted Shares Outstanding (Quarterly) Chart

View Average Diluted Shares Outstanding (Quarterly) for NKTR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Average Diluted Shares Outstanding (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Average Diluted Shares Outstanding (Quarterly) Range, Past 5 Years

View Average Diluted Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Average Diluted Shares Outstanding (Quarterly) Benchmarks

View Average Diluted Shares Outstanding (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Aquestive Therapeutics, Inc. Upgrade
Boston Scientific Corp. Upgrade
Esperion Therapeutics, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade